Pulmonary disposition of vancomycin in critically ill patients

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 5, 1997, Pages 385-388

  Georges, H ^a   Leroy, O ^a   Alfandari, S ^a   Guery, B ^a   Roussel Delvallez, M ^b   Dhennain, C ^c   Beaucaire, G ^a  

^a Serv Univ Reanimation Med M   (France)

^b UNIV LILLE   (France)

^c Hopital Chatilliez   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ADULT; AGED; ARTICLE; ASSISTED VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG; LUNG ALVEOLUS EPITHELIUM; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PNEUMONIA; PRIORITY JOURNAL;

AGED; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CRITICAL ILLNESS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 0030953042     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01726369     Document Type: Article

References (13)

1. Rello J, Torres A, Ricart M, Valles MJ, Gonzales J, Artigas A, Rodriguez-Roisin R: Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. American Journal of Respiratory and Critical Care Medicine 1994, 150: 1545-1549.
2. Baldwin DR, Honeybourne D, Wise R: Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrobial Agents and Chemotherapy 1992, 36: 1171-1175.
3. Lamer C, de Becq V, Soler P, Calvat S, Fagon JY, Dombret MC, Farinotti R, Chastre J, Gibert C: Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrobial Agents and Chemotherapy 1993, 37: 281-286.
4. Rennard SI, Basset G, Lecossier D, O'Donnel KM, Pinkston P, Martin PG, Crystal RG: Estimation of volume of epithelium lining fluid recovered by lavage using urea as marker of dilution. Journal of Applied Physiology 1986, 60: 532-538.
5. Murray JF, Matthay MA, Luce JM, Flick MR: An expanded definition of the adult respiratory distress syndrome. American Review of Respiratory Disease 1988, 138: 720-723.
6. Yao JDC, Moellering RC: Antibacterial agents: glycopeptides and lipopeptides. In: Balows A, Hausler WJ, Herrman KL, Isenberg HD, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington DC, 1991, p. 1076-1077.
7. National Committee for Clinical Laboratory Standards: Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard A7-A3. NCCLS, Villanova, PA, 1993.
8. Rotschafer JC, Crossley K, Zaske DE, Mead K, Sawchuk R, Solem LD: Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations. Antimicrobial Agents and Chemotherapy 1982, 22: 391-394.
9. Saunders NJ: Vancomycin administration and monitoring reappraisal. Journal of Antimicrobial Chemotherapy 1995, 36: 279-282.
10. Matzke GR, Zhanel GG, Guay DRP: Clinical pharmacokinetics of vancomycin. Clinical Pharmacokinetics 1986, 11: 257-282.
11. Sorrell TC, Collignon PJ: A prospective study of adverse reactions associated with vancomycin therapy. Journal of Antimicrobial Chemotherapy 1985, 16: 235-241.
12. Eng RHK, Wynn L, Smith SM, Tecson-Tumany F: Effect of intravenous vancomycin on renal function. Chemotherapy 1989, 35: 320-325.
13. Farber BF, Moellering RC: Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy 1983, 23: 138-141.